Fate Therapeutics, Inc.
Extract: Charter Amendment (Plain English Desc) from a 8-K on 06/07/2021   Download
SEC Document
SEC Filing

On June 2, 2021, the stockholders of Fate Therapeutics, Inc. (the “Company”) approved an amendment to the Company’s Amended and Restated Certificate of Incorporation to increase the number of authorized shares of the Company’s common stock, par value $0.001 per share (“Common Stock”), from 150,000,000 shares to 250,000,000 shares. A copy of the Certificate of Amendment to the Company’s Amended and Restated Certificate of Incorporation reflecting the foregoing amendment filed with the Secretary of State of the State of Delaware is attached hereto as Exhibit 3.1.